Eisai

Key TakeawaysColumvi plus GemOx demonstrated a statistically significant and clinically meaningful improvement in overall survival. The fixed-duration treatment offers a timely option post-diagnosis...

Key TakeawaysBoehringer Ingelheim launches VETMEDIN® Solution, the first FDA-approved oral liquid for congestive heart failure in dogs. This innovative solution addresses heart disease...

Biogen Japan has announced a groundbreaking research initiative focused on the APOE gene, a critical factor in Alzheimer's disease (AD) progression. Spearheaded by CEO...

The U.S. Food and Drug Administration has initiated a swift evaluation to address the rising misuse of ADHD prescription stimulants among adults. This comprehensive...

The U.S. Food and Drug Administration announced several significant updates today, addressing sterilization policies, drug approvals, and food safety measures to safeguard public health.   New...

Key TakeawaysAdopt advanced technologies to streamline operations and enhance product offerings. Focus on sustainability initiatives to align with consumer preferences and regulatory standards. ...

Key TakeawaysThe 35mg dosage regimen was well-tolerated, with minimal severe side effects. Patients exhibited a 30% increase in overall survival rates. The targeted...